PRJNA542146
Impact of levofloxacin for the prophylaxis of bloodstream infection on the gut microbiome in patients with hematologic malignancy
We evaluated the differential impact of levofloxacin administered for the prophylaxis of bloodstream infections compared to broad-spectrum beta-lactam (BSBL) antibiotics used for the treatment of neutropenic fever on the gut microbiome in patients with hematologic malignancy.